We would like to inform you that due to unforeseen circumstances beyond the organizer control, the "12th Edition of the Global Conference on Pharmaceutics and Novel Drug Delivery Systems" (Pharma-2025), originally scheduled for March 13-15, 2025 | Hybrid Event has been postponed. The updated dates and venue are September 11-13, 2025 | Valencia, Spain. For more details, please visit: https://pharmaceuticsconference.com/
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at pharmadds@magnusconference.com or call + 1 (702) 988 2320.
SARS (Severe Acute Respiratory Syndrome) is a type of acute respiratory syndrome. Coronavirus-2 (SARS-CoV-2) is the virus that causes COVID-19, which has spread globally. However, there is no precise drug that can prevent or treat COVID-19 at this time. Researchers from all over the world are striving to find the most effective ways to treat and prevent COVID-19, from repurposing existing medications to developing novel antiviral therapies. A list of repurposed drugs with significant pharmacological effects and therapeutic efficacies in treating COVID-19 patients might be developed, according to fresh research and clinical data on the virologic SARS-CoV-2.
Title : Liver biopsy handling of Metabolic-Associated Fatty Liver Disease (MAFLD): The children's hospital of eastern Ontario grossing protocol
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Haptoglobin-Related Protein Without Signal Peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States
Title : Enabling knowledge-driven integration and interoperability in intelligent and ethical transformed health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets. Discovery of agonists and antagonists of OR51E1, an understudied G Protein-Coupled Receptor
Vladlen Slepak, University of Miami, United States
Title : Revolutionizing healthcare and pharma: Artificial intelligence-powered scientific communications and medical writing
Alessandro Gallo, Springer Healthcare, Italy
Title : Understanding drug transport in plasma: the role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign-driven biotech and upgraded biomarketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Cell viability assays under radiofrequency application modulated by nanomaterials
Paulo C De Morais, Catholic University of Brasilia, Brazil
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Biosimilars - The current progress
Miroslav Radenkovic, University of Belgrade, Serbia